Rapid Response in a Crisis
A biotechnology company that incubated in the Faculty of Sciences at the University of the Republic, ATGen previously served health-care service providers who purchased clinical services, diagnostic reagents, and recombinant proteins.
At the onset of the COVID-19 pandemic in 2020, ATGen anticipated the need for effective testing and quickly started producing RNA extraction kits, as well as RT-PCR and antibody testing kits. ATGen soon found itself in the unique position to help address the surging demand for COVID-19 testing as other clinical labs and healthcare institutions were overwhelmed. They quickly pivoted their business strategy to also provide their services to the public directly.